Franchini F - Search Results

1

Time to diagnosis and treatment of lung cancer: A systematic overview of risk factors, interventions and impact on patient outcomes.

Zhang J, IJzerman MJ, Oberoi J, Karnchanachari N, Bergin RJ, Franchini F, Druce P, Wang X, Emery JD. Zhang J, et al. Among authors: franchini f. Lung Cancer. 2022 Apr;166:27-39. doi: 10.1016/j.lungcan.2022.01.015. Epub 2022 Jan 25. Lung Cancer. 2022. PMID: 35152171 Review.

2

An inverse stage-shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID-19 pandemic.

Degeling K, Baxter NN, Emery J, Jenkins MA, Franchini F, Gibbs P, Mann GB, McArthur G, Solomon BJ, IJzerman MJ. Degeling K, et al. Among authors: franchini f. Asia Pac J Clin Oncol. 2021 Aug;17(4):359-367. doi: 10.1111/ajco.13505. Epub 2021 Feb 10. Asia Pac J Clin Oncol. 2021. PMID: 33567163 Free PMC article.

3

Real world outcomes in KRAS G12C mutation positive non-small cell lung cancer.

Cui W, Franchini F, Alexander M, Officer A, Wong HL, IJzerman M, Desai J, Solomon BJ. Cui W, et al. Among authors: franchini f. Lung Cancer. 2020 Aug;146:310-317. doi: 10.1016/j.lungcan.2020.06.030. Epub 2020 Jun 26. Lung Cancer. 2020. PMID: 32619782

4

Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians.

Chazan G, Franchini F, Alexander M, Banerjee S, Mileshkin L, Blinman P, Zielinski R, Karikios D, Pavlakis N, Peters S, Lordick F, Ball D, Wright G, I Jzerman M, Solomon B. Chazan G, et al. Among authors: franchini f. ESMO Open. 2020 Dec;5(6):e001090. doi: 10.1136/esmoopen-2020-001090. ESMO Open. 2020. PMID: 33262203 Free PMC article.

5

Comparing Survival Outcomes for Advanced Cancer Patients Who Received Complex Genomic Profiling Using a Synthetic Control Arm.

O'Haire S, Degeling K, Franchini F, Tran B, Luen SJ, Gaff C, Smith K, Fox S, Desai J, IJzerman M. O'Haire S, et al. Among authors: franchini f. Target Oncol. 2022 Sep;17(5):539-548. doi: 10.1007/s11523-022-00910-0. Epub 2022 Sep 5. Target Oncol. 2022. PMID: 36063280 Free PMC article.

6

Impact of COVID-19 on cancer service delivery: a follow-up international survey of oncology clinicians.

Chazan G, Franchini F, Alexander M, Banerjee S, Mileshkin L, Blinman P, Zielinski R, Karikios D, Pavlakis N, Peters S, Lordick F, Ball D, Wright G, IJzerman M, Solomon BJ. Chazan G, et al. Among authors: franchini f. ESMO Open. 2021 Oct;6(5):100224. doi: 10.1016/j.esmoop.2021.100224. Epub 2021 Jul 9. ESMO Open. 2021. PMID: 34461484 Free PMC article.

7

The histone methyltransferase SMYD1 is induced by thermogenic stimuli in adipose tissue.

Cicatiello AG, Nappi A, Franchini F, Nettore IC, Raia M, Rocca C, Angelone T, Dentice M, Ungaro P, Macchia PE. Cicatiello AG, et al. Among authors: franchini f. Epigenomics. 2024 Mar;16(6):359-374. doi: 10.2217/epi-2023-0381. Epub 2024 Mar 5. Epigenomics. 2024. PMID: 38440863

8

A tailored approach to horizon scanning for cancer medicines.

Soon JA, To YH, Alexander M, Trapani K, Ascierto PA, Athan S, Brown MP, Burge M, Haydon A, Hughes B, Itchins M, John T, Kao S, Koopman M, Li BT, Long GV, Loree JM, Markman B, Meniawy TM, Menzies AM, Nott L, Pavlakis N, Petrella TM, Popat S, Tie J, Xu W, Yip D, Zalcberg J, Solomon BJ, Gibbs P, McArthur GA, Franchini F, IJzerman M. Soon JA, et al. Among authors: franchini f. J Cancer Policy. 2023 Dec;38:100441. doi: 10.1016/j.jcpo.2023.100441. Epub 2023 Nov 20. J Cancer Policy. 2023. PMID: 38008488 Free article.

9

Implementing competing risks in discrete event simulation: the event-specific probabilities and distributions approach.

Franchini F, Fedyashov V, IJzerman MJ, Degeling K. Franchini F, et al. Front Pharmacol. 2023 Oct 30;14:1255021. doi: 10.3389/fphar.2023.1255021. eCollection 2023. Front Pharmacol. 2023. PMID: 37964874 Free PMC article.

10

Anomalous Diffusion in the Long-Range Haken-Strobl-Reineker Model.

Catalano AG, Mattiotti F, Dubail J, Hagenmüller D, Prosen T, Franchini F, Pupillo G. Catalano AG, et al. Among authors: franchini f. Phys Rev Lett. 2023 Aug 4;131(5):053401. doi: 10.1103/PhysRevLett.131.053401. Phys Rev Lett. 2023. PMID: 37595217

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

141 results

Search Page